136 related articles for article (PubMed ID: 2552509)
1. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
Robberecht P; De Neef P; Gourlet P; Cauvin A; Coy DH; Christophe J
Regul Pept; 1989; 26(2):117-26. PubMed ID: 2552509
[TBL] [Abstract][Full Text] [Related]
2. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
[TBL] [Abstract][Full Text] [Related]
3. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
4. VIP receptors in human SUP-T1 lymphoblasts.
Christophe J; Cauvin A; Vervisch E; Buscail L; Damien C; Abello J; Gourlet P; Robberecht P
Digestion; 1990; 46 Suppl 2():148-55. PubMed ID: 1979777
[TBL] [Abstract][Full Text] [Related]
5. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
[TBL] [Abstract][Full Text] [Related]
6. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
7. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of VIP receptors in human lung membranes.
Robberecht P; Waelbroeck M; de Neef P; Camus JC; Coy DH; Christophe J
Peptides; 1988; 9(2):339-45. PubMed ID: 2836826
[TBL] [Abstract][Full Text] [Related]
9. VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line.
Robberecht P; De Neef P; Waelbroeck M; Tastenoy M; Christophe J
Peptides; 1989; 10(2):441-6. PubMed ID: 2474155
[TBL] [Abstract][Full Text] [Related]
10. Recovery of VIP/helodermin- and prostaglandin E1-stimulated adenylate cyclase activities in desensitized SUP-T1 human lymphoblasts.
Robberecht P; De Neef P; Abello J; Damien C; Coussaert E; Christophe J
Peptides; 1989; 10(5):1027-31. PubMed ID: 2558361
[TBL] [Abstract][Full Text] [Related]
11. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
12. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of helodermin-preferring VIP receptors in SUP T1 lymphoma cells: evidence for receptor glycosylation.
Gourlet P; Robberecht P; Christophe J
J Recept Res; 1991; 11(5):831-48. PubMed ID: 1656036
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
RodrĂguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P
Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
18. Homologous and heterologous regulation of the helodermin/vasoactive-intestinal-peptide response in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; Robberecht P; Hooghe R; Vandermeers A; Vandermeers-Piret MC; Christophe J
Eur J Biochem; 1989 Aug; 183(2):269-74. PubMed ID: 2547607
[TBL] [Abstract][Full Text] [Related]
19. Secretin receptors in human pancreatic membranes.
Robberecht P; De Neef P; Waelbroeck M; Camus JC; Scemama JL; Fourmy D; Pradayrol L; Vaysse N; Christophe J
Pancreas; 1988; 3(5):529-35. PubMed ID: 3186683
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]